SEC Info - Portnoy Mark L. - ‘4’ for 12/23/22 re: Cryo Cell International Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Portnoy Mark L.

(Last)

(First)

(Middle)

700 BROOKER CREEK BLVD

SUITE 1800

(Street)

OLDSMAR

34677

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
Co-CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/23/22

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								42,266	I	By 401K
Common Stock								71,529	I	By Partnership ⁽¹⁾
Common Stock								821,973	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$7.92							3/8/18	3/8/23	Common Stock	20,000		20,000	D
Stock Option	$7.53							8/30/19	8/30/29	Common Stock	22,222		22,222	D
Stock Option	$7.28							12/20/19	12/20/29	Common Stock	20,000		20,000	D
Stock Option	$13.5							12/22/21 ⁽²⁾ ⁽³⁾	12/22/24	Common Stock	20,000		20,000	D
Stock Option	$12.27							12/22/21 ⁽²⁾ ⁽⁴⁾	12/22/28	Common Stock	100,000		100,000	D
Stock Option	$4.77							1/3/23 ⁽⁵⁾	1/3/28	Common Stock	25,000		25,000	D
Stock Option	$4.3	12/23/22		A		25,000		12/23/22 ⁽⁶⁾	12/23/27	Common Stock	25,000	$4.3	25,000	D

Explanation of Responses:

(1) Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.

(2) The stock options are subject to the approval of the 2022 Equity Incentive Plan, which vote is expected to occur at the Company's 2022 Annual Meeting.

(3) One-third of the stock options will vest on December 22, 2022, one-third will vest on December 22, 2023 and one-third on December 22, 2024.

(4) Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.

(5) 11,250 options vest upon issuance, 11,250 options vest on 1/2/24 and 2,500 options vest on 1/2/25.

(6) Pursuant to the executive's Employment Agreement effective December 1, 2022, stock options will be awarded and will vest immediately if the price of the Company's stock reaches $8.00 per share during the five-year option term.

Remarks:

	/s/ Mark Portnoy	1/6/23
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Code:
A	Grant, award or other acquisition pursuant to Rule 16b-3(d).

Portnoy Mark L. – ‘4’ for 12/23/22 re: Cryo Cell International Inc.

On: Friday, 1/6/23, at 5:00pm ET · For: 12/23/22 · As: Director, Officer and 10% Owner · Accession #: 1209191-23-2381 · File #: 1-40767

Previous ‘4’: ‘4’ on 1/5/23 for 1/3/23 · Next & Latest: ‘4’ on 12/28/23 for 12/22/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Portnoy Mark L. – ‘4’ for 12/23/22 re: Cryo Cell International Inc.

On: Friday, 1/6/23, at 5:00pm ET · For: 12/23/22 · As: Director, Officer and 10% Owner · Accession #: 1209191-23-2381 · File #: 1-40767

Previous ‘4’: ‘4’ on 1/5/23 for 1/3/23 · Next & Latest: ‘4’ on 12/28/23 for 12/22/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents